title: More blockbusters on the way. Pharmaceutical spending and the impact of pipeline drugs.
abstract: Prescription drug spending continues to increase annually and continued growth is expected over the next few years, fueled by potential blockbuster drugs currently being developed by pharmaceutical manufacturers. In 2000, Blue Cross Blue Shield of Michigan (BCBSM) prescription drug expenditures for Michigan residents represented 26.4 percent of total BCBSM payments, while payments for inpatient hospital services accounted for 19.7 percent of total BCBSM payments.
authors.affiliation: Blue Cross Blue Shield of Michigan, Detroit, USA. akaddis@bcbsm.com
authors.forename: A
authors.initials: A
authors.lastname: Kaddis
mesh_terms: D016527:Drug Costs / Q000639:trends*; D015195:Drug Design; D015507:Drugs, Investigational / Q000191:economics*; D017850:Economics, Pharmaceutical / Q000639:trends*; D006801:Humans; D008824:Michigan; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D015507:Drugs, Investigational